• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用减毒活疫苗与灭活疫苗联合进行乙型脑炎免疫接种策略的研究]

[Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].

作者信息

Ma Fu-bao, Zheng Li, Bi Cheng, Tao Hong, Zhou Yong-lin, Zhang Jin-lin, Tang Fen-yang, Xie Ping, Zheng Chun-zao, Peng Wei-bin, Jiang Ren-jie

机构信息

Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210009, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Feb;24(2):113-5.

PMID:12697111
Abstract

OBJECTIVE

Using the advantages of Japanese encephalitis live attenuated and inactivated vaccine, to reduce the rate of immunization reaction and to increase the effect, we conducted a study on the strategy of immunization in Japanese encephalitis using live attenuated vaccine combined with inactivated vaccine.

METHODS

Observing the safety and immune effects of different groups.

RESULTS

Data on side effect showed that the rate of moderate and severe systematic reactions of the group who were inoculated with combined vaccine was 0.73%, with local reaction 1.46% while the combined rate of moderate and severe systematic reaction of the group who were inoculated with inactivated vaccine was 2.8%. Under the detection of serum neutralizing antibody, the GMT rose from 1:1.05 - 1:3.35 before vaccination to 1:47.34 - 1:101.30 after vaccination in the different groups. Neutralizing antibody was detected in 97.67% of the combined group. There was a significant difference by comparing neutralizing antibody seroconversion rate of the combined group with the inactivated group (chi(2) = 3.89, P < 0.05), but no significant difference with attenuated group (chi(2) = 0.74, P > 0.05).

CONCLUSION

Results showed that in children who previously had been immunized with two doses of inactivated vaccine, the booster administration of live attenuated vaccine was both effective and safe.

摘要

目的

利用乙型脑炎减毒活疫苗和灭活疫苗的优势,降低免疫反应发生率并提高免疫效果,我们开展了一项关于使用减毒活疫苗与灭活疫苗联合进行乙型脑炎免疫策略的研究。

方法

观察不同组别的安全性和免疫效果。

结果

副作用数据显示,接种联合疫苗组的中重度全身反应发生率为0.73%,局部反应发生率为1.46%,而接种灭活疫苗组的中重度全身反应合并发生率为2.8%。在血清中和抗体检测下,不同组别的几何平均滴度(GMT)从接种前的1:1.05 - 1:3.35升至接种后的1:47.34 - 1:101.30。联合组97.67%检测到中和抗体。联合组与灭活组比较中和抗体血清转化率有显著差异(χ² = 3.89,P < 0.05),但与减毒组比较无显著差异(χ² = 0.74,P > 0.05)。

结论

结果表明,对于先前已接种两剂灭活疫苗的儿童,加强接种减毒活疫苗既有效又安全。

相似文献

1
[Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].[使用减毒活疫苗与灭活疫苗联合进行乙型脑炎免疫接种策略的研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Feb;24(2):113-5.
2
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.嵌合型减毒活乙型脑炎疫苗(ChimeriVax-JE):安全性和免疫原性的2期临床试验、疫苗剂量和接种程序的效果以及对灭活乙型脑炎抗原攻击的记忆反应
J Infect Dis. 2003 Oct 15;188(8):1213-30. doi: 10.1086/378356. Epub 2003 Oct 3.
3
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.单剂量减毒活SA14-14-2日本脑炎疫苗接种儿童抗体反应的5年随访:免疫原性和回忆反应
Vaccine. 2008 Mar 20;26(13):1638-43. doi: 10.1016/j.vaccine.2008.01.021. Epub 2008 Feb 4.
4
[Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
Zhonghua Liu Xing Bing Xue Za Zhi. 1998 Apr;19(2):97-9.
5
[A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].[流行性乙型脑炎(乙脑)活疫苗(SA14-14-2)在乙脑流行地区的安全性及流行病学效果的大规模研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 1999 Feb;20(1):38-41.
6
Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.在泰国为9至15个月大的儿童接种减毒活SA14-14-2日本脑炎疫苗。
J Med Assoc Thai. 2011 Aug;94 Suppl 3:S195-203.
7
Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?儿童接种减毒活日本脑炎疫苗后是否需要加强免疫?
J Trop Pediatr. 2013 Oct;59(5):423-5. doi: 10.1093/tropej/fmt043. Epub 2013 Jun 13.
8
Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.表达中和表位和M.T hsp70的日本脑炎蛋白疫苗候选物在猪体内诱导病毒特异性记忆B细胞和持久抗体。
Vaccine. 2008 Oct 16;26(44):5590-4. doi: 10.1016/j.vaccine.2008.07.104. Epub 2008 Aug 30.
9
Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.初免一剂vero 细胞培养灭活流行性乙型脑炎疫苗(JE-VC)后的长期免疫原性,以及既往接种过鼠脑源灭活流行性乙型脑炎疫苗儿童再次接种JE-VC 疫苗的安全性和免疫原性。
Vaccine. 2018 Mar 7;36(11):1398-1404. doi: 10.1016/j.vaccine.2018.01.075.
10
Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.单次接种减毒活日本脑炎疫苗在既往初免 2 至 5 岁儿童和初免 12 至 24 月龄儿童中的安全性和免疫原性:多中心随机对照试验。
Pediatr Infect Dis J. 2010 Dec;29(12):1111-7. doi: 10.1097/INF.0b013e3181f68e9c.

引用本文的文献

1
Vaccines for preventing Japanese encephalitis.预防日本脑炎的疫苗。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004263. doi: 10.1002/14651858.CD004263.pub2.